U.S. drops another $2.1B for doses of experimental coronavirus vaccine candidate

1 week ago 7
Pharma giants GlaxoSmithKline and Sanofi Pasteur announced Friday they will supply 100 million doses of an experimental COVID-19 vaccine to the United States.
Read Entire Article